Acer医疗(ACER)

1.61 -0.02 -1.227%

今开:1.6昨收:1.63
最高:1.65 最低:1.53
涨停价:0.0跌停价:0.0
总市值:2.6361514E7

Acer医疗的热门评论

产业链观察06-21 20:46

药闻▶2022年6月21日,$Acer医疗(ACER)$ 及其合作夥伴RELIEF THERAPEUTICS Holding SA今天宣布,美国今天宣布,美国食品和药物管理局(FDA)已经就ACER-001(苯丁酸钠)口服混悬液治疗尿素循环障碍(UCDs)患者的新药申请(NDA)发出了#完全回应函(CRL)# 。
该CRL表明,FDA不能...查看全文

产业链观察04-04 21:18

药闻▶$Acer医疗(ACER)$ EDSIVO (celiprolol) 获得 FDA 对血管性 Ehlers-Danlos 综合征的突破性治疗指定查看全文

当期报告

Acer医疗(ACER)11-30 06:06

$Acer医疗(ACER)$ 8-K Current report, item 3.01 Accession Number: 0001564590-22-038569 Act: 34 Size: 168 KB 网页链接查看全文

当期报告

Acer医疗(ACER)11-30 21:42

$Acer医疗(ACER)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001564590-22-038602 Act: 34 Size: 398 KB 网页链接查看全文

季度财报「修正」

Acer医疗(ACER)11-15 06:12

$Acer医疗(ACER)$ 10-Q/A [Amend] Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-22-037667 Act: 34 Size: 10 MB 网页链接查看全文

当期报告

Acer医疗(ACER)11-15 06:18

$Acer医疗(ACER)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-22-037670 Act: 34 Size: 413 KB 网页链接查看全文

当期报告

Acer医疗(ACER)11-15 06:03

$Acer医疗(ACER)$ 8-K Current report, items 2.02 and 4.02 Accession Number: 0001564590-22-037660 Act: 34 Size: 182 KB 网页链接查看全文

季度财报

Acer医疗(ACER)11-15 06:33

$Acer医疗(ACER)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-22-037680 Act: 34 Size: 10 MB 网页链接查看全文

当期报告

Acer医疗(ACER)10-26 21:06

$Acer医疗(ACER)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001564590-22-035194 Act: 34 Size: 234 KB 网页链接查看全文

当期报告

Acer医疗(ACER)10-06 21:06

$Acer医疗(ACER)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001564590-22-033641 Act: 34 Size: 249 KB 网页链接查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Acer医疗的最新评论

Acer医疗(ACER)2019-10-29 20:35

$Acer医疗(ACER)$ 8-K - Current report Filed: 2019-10-29 AccNo: 0001564590-19-038182 Size: 12 MBItem 7.01: Regulation FD DisclosureItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Acer医疗(ACER)2019-08-20 08:30

$Acer医疗(ACER)$ 8-K/A [Amend] - Current report Filed: 2019-08-19 AccNo: 0001564590-19-032528 Size: 33 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接查看全文

Acer医疗(ACER)2019-08-14 08:30

$Acer医疗(ACER)$ 8-K - Current report Filed: 2019-08-13 AccNo: 0001564590-19-031800 Size: 12 MBItem 2.02: Results of Operations and Financial ConditionItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Acer医疗(ACER)2019-08-14 08:30

$Acer医疗(ACER)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2019-08-13 AccNo: 0001564590-19-031810 Size: 4 MB 网页链接查看全文

Acer医疗(ACER)2019-08-06 08:30

$Acer医疗(ACER)$ 8-K - Current report Filed: 2019-08-05 AccNo: 0001564590-19-028533 Size: 14 MBItem 7.01: Regulation FD DisclosureItem 9.01: Financial Statements and Exhibits 网页链接查看全文

Acer医疗(ACER)2019-07-06 08:25

$Acer医疗(ACER)$ 8-K - Current report Filed: 2019-07-05 AccNo: 0001564590-19-024572 Size: 65 KBItem 2.05: Cost Associated with Exit or Disposal ActivitiesItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接查看全文

临床试验规模太小,罕见病新药上市申请遭FDA拒绝

医药魔方2019-06-27 08:07

6月25日,Acer Therapeutics宣布收到FDA的完全回应函(CRL),FDA暂时拒绝了该公司开发的治疗血管性Ehlers-Danlos综合征(vEDS)新药Edsivo(celiprolol)的上市申请(NDA)。
EDS是结缔组织的一组遗传性疾病,其中vEDS是最严重的亚型,患者平均寿命为51岁。vEDS患者除肠道和子宫会发生破裂外...查看全文

Acer医疗(ACER)2019-06-26 08:30

$Acer医疗(ACER)$ 8-K - Current report Filed: 2019-06-25 AccNo: 0001564590-19-023312 Size: 50 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接查看全文

conkers2019-06-25 22:47

$Acer医疗(ACER)$ 原来不是失败。只是CRL.查看全文

瓮里主公怎个愁2019-06-25 21:58

$Acer医疗(ACER)$ 医药股真是崩溃查看全文

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

Acer医疗的公告

发行公告

$Acer医疗(ACER)$ D Notice of Exempt Offering of Securities, item 06b Accession Number: 0001209191-22-059517 Act: 33 Size: 16 KB 网页链接

超过5%股东持股披露「修订」

$Acer医疗(ACER)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001193125-22-297521 Act: 34 Size: 38 KB 网页链接

持股变动声明

$Acer医疗(ACER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-059172 Size: 4 KB 网页链接

持股变动声明

$Acer医疗(ACER)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-22-059174 Size: 4 KB 网页链接

当期报告

$Acer医疗(ACER)$ 8-K Current report, items 1.01, 3.02, and 9.01 Accession Number: 0001564590-22-038602 Act: 34 Size: 398 KB 网页链接

当期报告

$Acer医疗(ACER)$ 8-K Current report, item 3.01 Accession Number: 0001564590-22-038569 Act: 34 Size: 168 KB 网页链接

季度财报

$Acer医疗(ACER)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-22-037680 Act: 34 Size: 10 MB 网页链接

当期报告

$Acer医疗(ACER)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-22-037670 Act: 34 Size: 413 KB 网页链接

季度财报「修正」

$Acer医疗(ACER)$ 10-Q/A [Amend] Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-22-037667 Act: 34 Size: 10 MB 网页链接

当期报告

$Acer医疗(ACER)$ 8-K Current report, items 2.02 and 4.02 Accession Number: 0001564590-22-037660 Act: 34 Size: 182 KB 网页链接

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23